Literature DB >> 27736836

Surveillance for Silicosis - Michigan and New Jersey, 2003-2011.

Patricia L Schleiff1, Jacek M Mazurek1, Mary Jo Reilly2, Kenneth D Rosenman2, Martha B Yoder3, Margaret E Lumia4, Karen Worthington4.   

Abstract

CDC's National Institute for Occupational Safety and Health (NIOSH), state health departments, and other state entities maintain a state-based surveillance program of confirmed silicosis cases. Data on confirmed cases are collected and compiled by state entities and submitted to CDC. This report summarizes information for cases of silicosis that were reported to CDC for 2003-2011 by Michigan and New Jersey, the only states that continue to provide data voluntarily to NIOSH. The data for this report were final as of January 8, 2015. Data are presented in tabular form on the number and distribution of cases of silicosis by year (Table 1), duration of employment in occupations with potential exposure to dust containing respirable crystalline silica (Table 2), industry (Table 3), and occupation (Table 4). The number of cases by year is presented graphically (Figure). This report is a part of the Summary of Notifiable Noninfectious Conditions and Disease Outbreaks - United States, which encompasses various surveillance years but is being published in 2016 (1). The Summary of Notifiable Noninfectious Conditions and Disease Outbreaks appears in the same volume of MMWR as the annual Summary of Notifiable Infectious Diseases (2).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27736836     DOI: 10.15585/mmwr.mm6355a7

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  7 in total

1.  Silicosis prevalence and incidence among Medicare beneficiaries.

Authors:  Megan L Casey; Jacek M Mazurek
Journal:  Am J Ind Med       Date:  2019-01-18       Impact factor: 2.214

2.  Evaluating the use of a field-based silica monitoring approach with dust from copper mines.

Authors:  Emanuele Cauda; Lauren Chubb; Rustin Reed; Robert Stepp
Journal:  J Occup Environ Hyg       Date:  2018-10       Impact factor: 2.155

3.  Mapping of Dynamic Transcriptome Changes Associated With Silica-Triggered Autoimmune Pathogenesis in the Lupus-Prone NZBWF1 Mouse.

Authors:  Melissa A Bates; Abby D Benninghoff; Kristen N Gilley; Andrij Holian; Jack R Harkema; James J Pestka
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

4.  N-acetylcysteine tiherapeutically protects against pulmonary fibrosis in a mouse model of silicosis.

Authors:  Huaping Huang; Mingjing Chen; Feng Liu; Haifeng Wu; Jie Wang; Jialiang Chen; Meihua Liu; Xi Li
Journal:  Biosci Rep       Date:  2019-07-18       Impact factor: 3.840

5.  Global and national burden and trends of mortality and disability-adjusted life years for silicosis, from 1990 to 2019: results from the Global Burden of Disease study 2019.

Authors:  Shimin Chen; Miao Liu; Fei Xie
Journal:  BMC Pulm Med       Date:  2022-06-21       Impact factor: 3.320

6.  Dioscin Exerts Protective Effects Against Crystalline Silica-induced Pulmonary Fibrosis in Mice.

Authors:  Chao Li; Yiping Lu; Sitong Du; Siyi Li; Yiting Zhang; Fangwei Liu; Ying Chen; Dong Weng; Jie Chen
Journal:  Theranostics       Date:  2017-09-26       Impact factor: 11.556

7.  Dietary Docosahexaenoic Acid Prevents Silica-Induced Development of Pulmonary Ectopic Germinal Centers and Glomerulonephritis in the Lupus-Prone NZBWF1 Mouse.

Authors:  Melissa A Bates; Peyman Akbari; Kristen N Gilley; James G Wagner; Ning Li; Anna K Kopec; Kathryn A Wierenga; Daven Jackson-Humbles; Christina Brandenberger; Andrij Holian; Abby D Benninghoff; Jack R Harkema; James J Pestka
Journal:  Front Immunol       Date:  2018-09-12       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.